STAT3 and neoplasm: Moreover, STAT3 downstream of EGFR signaling pathway could promote the transcription of UTX, suggesting an “EGFR-STAT3-UTX” axis that participates in the progression of NSCLC, and can at least partly explain the higher levels of UTX in NSCLC tumor tissues comparing to normal samples.